严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
病毒学
2019年冠状病毒病(COVID-19)
2019-20冠状病毒爆发
Sars病毒
生物
医学
内科学
爆发
传染病(医学专业)
疾病
作者
Yu Kaku,Kaho Okumura,Shusuke Kawakubo,Keiya Uriu,Chen Luo,Yusuke Kosugi,Yoshifumi Uwamino,MST Monira Begum,Sharee Leong,Terumasa Ikeda,Kenji Sadamasu,Hiroyuki Asakura,Mami Nagashima,Kazuhisa Yoshimura,Jumpei Ito,Kei Sato
标识
DOI:10.1016/s1473-3099(24)00731-x
摘要
The SARS-CoV-2 JN.1 (BA.2.86.1.1) variant, arising from BA.2.86.1 with spike protein (S) substitution S:L455S, outcompeted the previously predominant XBB lineages by the beginning of 2024.1 Subsequently, JN.1 subvariants including KP.2 (JN.1.11.1.2) and KP.3 (JN.1.11.1.3), which acquired additional S substitutions (eg, S:R346T, S:F456L, and S:Q493E), have emerged concurrently (appendix pp 19–20).2,3 As of October 2024, KP.3.1.1 (JN.1.11.1.3.1.1), which acquired S:31del, outcompeted other JN.1 subvariants including KP.2 and KP.3, and is the most predominant SARS-CoV-2 variant in the world.
科研通智能强力驱动
Strongly Powered by AbleSci AI